Last 12 months
Inside the activity.
10 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 6 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 2 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2023 Filed Jun 13, 2023 18:44 UTC |
Diaz StephanieDirector
|
GrantRestricted Stock Units · Derivative | 6,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021126 · ownership.xml · derivative · entry 1 Diaz Stephanie · CIK 0001850265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,980 Underlying: Common Stock · 6,980 shares Expires not disclosed F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant. F3 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
Wei BinxianDirector
|
GrantCommon Stock Options · Derivative | 9,580 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021127 · ownership.xml · derivative · entry 2 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,580 Underlying: Common Stock · 9,580 shares Expires 2033-06-11 F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
Wei BinxianDirector
|
GrantRestricted Stock Units · Derivative | 6,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021127 · ownership.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,980 Underlying: Common Stock · 6,980 shares Expires not disclosed F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant. F3 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
Csimma CristinaDirector
|
GrantCommon Stock Options · Derivative | 9,580 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021128 · ownership.xml · derivative · entry 2 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,580 Underlying: Common Stock · 9,580 shares Expires 2033-06-11 F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
Csimma CristinaDirector
|
GrantRestricted Stock Units · Derivative | 6,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021128 · ownership.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,980 Underlying: Common Stock · 6,980 shares Expires not disclosed F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant. F3 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
GRAY MARY ANNDirector
|
GrantCommon Stock Options · Derivative | 12,160 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021132 · ownership.xml · derivative · entry 2 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,160 Underlying: Common Stock · 12,160 shares Expires 2033-06-11 F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
GRAY MARY ANNDirector
|
GrantRestricted Stock Units · Derivative | 5,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021132 · ownership.xml · derivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,100 Underlying: Common Stock · 5,100 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F3 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
Neal James RDirector
|
GrantCommon Stock Options · Derivative | 12,160 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021130 · ownership.xml · derivative · entry 2 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,160 Underlying: Common Stock · 12,160 shares Expires 2033-06-11 F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:44 UTC |
Neal James RDirector
|
GrantRestricted Stock Units · Derivative | 5,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021130 · ownership.xml · derivative · entry 1 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,100 Underlying: Common Stock · 5,100 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F3 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:43 UTC |
Williams Donald AllenDirector
|
GrantCommon Stock Options · Derivative | 12,160 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021129 · ownership.xml · derivative · entry 2 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,160 Underlying: Common Stock · 12,160 shares Expires 2033-06-11 F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:43 UTC |
Williams Donald AllenDirector
|
GrantRestricted Stock Units · Derivative | 5,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021129 · ownership.xml · derivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,100 Underlying: Common Stock · 5,100 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F3 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 18:52 UTC |
McRae Robert CurtisChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 655 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-011082 · ownership.xml · derivative · entry 3 McRae Robert Curtis · CIK 0001965845 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,963 Underlying: Common Stock · 655 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F3 · derivative.exercise_date: This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F3 · derivative.expiration_date: This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 18:52 UTC |
McRae Robert CurtisChief Operating Officer
|
Tax withholdingCommon Stock, par value $0.01 | 270 | $2.00 | $540.00 |
DisclosureSEC source: 0001493152-23-011082 · ownership.xml · nonDerivative · entry 2 McRae Robert Curtis · CIK 0001965845 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625 F2 · security: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units. F2 · price: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 18:52 UTC |
McRae Robert CurtisChief Operating Officer
|
Exercise / conversionCommon Stock, par value $0.01 | 655 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-011082 · ownership.xml · nonDerivative · entry 1 McRae Robert Curtis · CIK 0001965845 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:49 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-011080 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,927 Underlying: Common Stock · 1,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F4 · derivative.exercise_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on April 3, 2023, and 1,309 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F4 · derivative.expiration_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on April 3, 2023, and 1,309 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:49 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 435 | $2.01 | $874.35 |
DisclosureSEC source: 0001493152-23-011080 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,848 F2 · security: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units. F2 · price: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:49 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-011080 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:01 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantCommon Stock Purchase Option · Derivative | 57,200 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001493152-23-003989 · ownership.xml · derivative · entry 3 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,200 Underlying: Common Stock · 57,200 shares Expires 2033-02-06 F1 · security: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F2 · security: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25 F1 · shares: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F2 · shares: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25 F1 · derivative.exercise_date: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F2 · derivative.exercise_date: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25 Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:01 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantRestricted Performance Stock Units · Derivative | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-003989 · ownership.xml · derivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2033-02-06 F1 · security: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F2 · security: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25 F3 · derivative.exercise_price: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F3 · shares: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F2 · derivative.exercise_date: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25 Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:01 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantRestricted Stock Units · Derivative | 41,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-003989 · ownership.xml · derivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 Underlying: Common Stock · 41,700 shares Expires not disclosed F1 · security: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F2 · security: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25 F3 · derivative.exercise_price: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F3 · shares: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received. F2 · derivative.exercise_date: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25 F4 · derivative.expiration_date: N/A Read SEC document |
| January 03, 2023 Filed Jan 7, 2023 00:42 UTC |
Finley John DavidChief Executive Officer
|
GrantRestricted Stock Units · Derivative | 5,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-000862 · ownership.xml · derivative · entry 1 Finley John David · CIK 0001851034 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,236 Underlying: Common Stock · 5,236 shares Expires not disclosed F1 · security: Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan. F1 · shares: Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan. F1 · derivative.exercise_date: Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24. F3 · derivative.expiration_date: N/A Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 22:21 UTC |
Finley John DavidChief Financial Officer
|
PurchaseCommon Stock, par value $0.01 | 19,481.242 | $0.14 | $2,799.45 |
DisclosureSEC source: 0001493152-22-025023 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,727.242 F1 · price: Reporting Person purchased 19,481.242 shares of Common Stock of Issuer at prices ranging from $0.1437 to $0.1439 with a weighted average price per share of $0.1437 on September 1 2022. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 21:10 UTC |
Finley John DavidChief Financial Officer
|
PurchaseCommon Stock, par value $0.01 | 7,350 | $0.16 | $1,176.00 |
DisclosureSEC source: 0001493152-22-024082 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,246 F1 · kind: Reporting Person purchased 7,350 shares of Common Stock of Issuer at a price per share of $0.16 on August 23, 2022. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 21:06 UTC |
Hallam ThomasDirector · Chief Executive Officer
|
PurchaseSeries 2 Common Stock Purchase Warrant · Derivative | 40,000 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001493152-22-023511 · ownership.xml · derivative · entry 3 Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-08-16 F3 · kind: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. F3 · derivative.exercise_date: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 21:06 UTC |
Hallam ThomasDirector · Chief Executive Officer
|
PurchaseSeries 1 Common Stock Purchase Warrant · Derivative | 40,000 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001493152-22-023511 · ownership.xml · derivative · entry 2 Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2023-08-16 F2 · kind: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. F2 · derivative.exercise_date: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 21:06 UTC |
Hallam ThomasDirector · Chief Executive Officer
|
PurchaseCommon Stock, par value $0.01 | 40,000 | $0.25 | $10,000.00 |
DisclosureSEC source: 0001493152-22-023511 · ownership.xml · nonDerivative · entry 1 Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,592 F1 · kind: Represents common shares underlying 40,000 Units of Issuer purchased by Reporting Person ("Units") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25. Read SEC document |
| August 16, 2022 Filed Aug 19, 2022 01:04 UTC |
Finley John DavidChief Financial Officer
|
PurchaseSeries 2 Common Stock Purchase Warrant · Derivative | 100,000 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001493152-22-023510 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-08-16 F4 · kind: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. F4 · derivative.exercise_date: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. Read SEC document |
| August 16, 2022 Filed Aug 19, 2022 01:04 UTC |
Finley John DavidChief Financial Officer
|
PurchaseSeries 1 Common Stock Purchase Warrant · Derivative | 100,000 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001493152-22-023510 · ownership.xml · derivative · entry 3 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-08-16 F3 · kind: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. F3 · derivative.exercise_date: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4. Read SEC document |
| August 16, 2022 Filed Aug 19, 2022 01:04 UTC |
Finley John DavidChief Financial Officer
|
PurchaseCommon Stock, par value $0.01 | 100,000 | $0.25 | $25,000.00 |
DisclosureSEC source: 0001493152-22-023510 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,896 F1 · kind: Represents common shares underlying 100,000 Units of Issuer purchased by Reporting Person ("Units") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25. Read SEC document |
| April 29, 2022 Filed May 2, 2022 21:34 UTC |
Finley John DavidChief Financial Officer
|
OtherCommon Stock | 12,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026450 · doc4.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By FCW Investments LLC Disclosed balance after: 38,867 F1 · kind: Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution. F1 · price: Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution. F2 · ownership.nature: The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 12:31 UTC |
Dawson Michael JohnChief Medical Officer
|
PurchaseCommon Stock | 15,000 | $1.14 | $17,092.50 |
DisclosureSEC source: 0001209191-22-021681 · doc4.xml · nonDerivative · entry 1 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| March 28, 2022 Filed Mar 29, 2022 08:37 UTC |
Hallam ThomasDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $1.18 | $11,800.00 |
DisclosureSEC source: 0001209191-22-021405 · doc4.xml · nonDerivative · entry 1 Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,592 Read SEC document |
| March 24, 2022 Filed Mar 25, 2022 12:01 UTC |
Finley John DavidChief Financial Officer
|
PurchaseCommon Stock | 7,500 | $1.09 | $8,174.25 |
DisclosureSEC source: 0001209191-22-021051 · doc4.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,896 Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 17:58 UTC |
Hallam ThomasDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 156,600 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001209191-22-011856 · doc4.xml · derivative · entry 1 Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,600 Underlying: Common Stock · 156,600 shares Expires 2032-02-16 F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:57 UTC |
Finley John DavidChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 64,800 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001209191-22-011855 · doc4.xml · derivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,800 Underlying: Common Stock · 64,800 shares Expires 2032-02-16 F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:54 UTC |
Dawson Michael JohnChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 32,400 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001209191-22-011853 · doc4.xml · derivative · entry 1 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,400 Underlying: Common Stock · 32,400 shares Expires 2032-02-16 F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 18:26 UTC |
Trenschel Robert J.Director
|
GrantStock Option (right to buy) · Derivative | 48,340 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008586 · doc4.xml · derivative · entry 1 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-11-17 F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 18:36 UTC |
Hallam ThomasDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 267,868 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008592 · doc4.xml · derivative · entry 1 Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,868 Underlying: Common Stock · 267,868 shares Expires 2031-11-17 F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 23:39 UTC |
Finley John DavidChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 178,091 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008594 · doc4.xml · derivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,091 Underlying: Common Stock · 178,091 shares Expires 2031-11-17 F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 18:16 UTC |
Diaz StephanieDirector
|
GrantStock Option (right to buy) · Derivative | 48,340 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008571 · doc4.xml · derivative · entry 1 Diaz Stephanie · CIK 0001850265 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-11-17 F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 23:40 UTC |
Dawson Michael JohnChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 39,294 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008596 · doc4.xml · derivative · entry 1 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,294 Underlying: Common Stock · 39,294 shares Expires 2031-11-17 F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 23:23 UTC |
Williams Donald AllenDirector
|
GrantStock Option (right to buy) · Derivative | 48,340 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008581 · doc4.xml · derivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-11-17 F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 23:19 UTC |
Neal James RDirector
|
GrantStock Option (right to buy) · Derivative | 48,340 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008575 · doc4.xml · derivative · entry 1 Neal James R · CIK 0001600865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-11-17 F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 23:11 UTC |
Wei BinxianDirector
|
GrantStock Option (right to buy) · Derivative | 48,340 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008569 · doc4.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-11-17 F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 23:02 UTC |
GRAY MARY ANNDirector
|
GrantStock Option (right to buy) · Derivative | 48,340 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008562 · doc4.xml · derivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-11-17 F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period. Read SEC document |
| November 18, 2021 Filed Feb 10, 2022 23:07 UTC |
Csimma CristinaDirector
|
GrantStock Option (right to buy) · Derivative | 48,340 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-22-008565 · doc4.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-11-17 F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 19:35 UTC |
Hallam ThomasDirector · Chief Executive Officer
|
PurchaseCommon Stock | 6,000 | $2.49 | $14,940.00 |
DisclosureSEC source: 0001209191-21-057318 · doc4.xml · nonDerivative · entry 1 Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,592 Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 23:36 UTC |
Finley John DavidChief Financial Officer
|
PurchaseCommon Stock | 2,000 | $2.44 | $4,880.00 |
DisclosureSEC source: 0001209191-21-057319 · doc4.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,396 Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 18:40 UTC |
Trenschel Robert J.Director
|
PurchaseCommon Stock | 2,142 | $2.98 | $6,383.16 |
DisclosureSEC source: 0001209191-21-055729 · doc4.xml · nonDerivative · entry 5 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,999 Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 18:40 UTC |
Trenschel Robert J.Director
|
PurchaseCommon Stock | 3,400 | $2.89 | $9,826.00 |
DisclosureSEC source: 0001209191-21-055729 · doc4.xml · nonDerivative · entry 4 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,857 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.